AU;Current Trials
Important update
Welcoming Pacific Clinical Research Network (PCRN) to Momentum

Our network has expanded. PCRN have joined us and rebranded to Momentum Clinical Research.

  • Home
  • Clinical Trials
  • Atopic Dermatitis Studies Wellington 37

Atopic Dermatitis Study

Wellington

Please note that this study has now closed. However, we encourage you to pre-register your interest for future atopic dermatitis studies here. 

Description

What to expect

Study details

Ages

18 to 65 years of age

Duration

The study runs for approximately 27 weeks, involving 15 visits to the clinic and 2 under-the-skin (subcutaneous) injections

Compensation

Participants will be compensated

Eligibility Criteria

You may qualify if you:

  • Are 18 to 65 years of age
  • Have a clinical diagnosis of moderate to severe atopic dermatitis (eczema) for at least 1 year
  • Have eczema that cannot be adequately controlled with topical medications (or if you are unable to use topical treatments)

Other criteria applies. A member of our team will check if this study is a good fit for you.

Locations

Wellington

Description

Atopic dermatitis, also known as eczema, is a chronic skin condition that can make your skin feel dry, itchy, and sore. It can come and go, showing up as red, irritated patches that may make daily life uncomfortable and have an impact on sleep, physical comfort and self-confidence.

Flare ups of symptoms can be caused by a wide range of triggers including changes in temperature, allergens in the environment or food, stress, certain clothing or fabrics and hormonal changes. With eczema, your skin’s protective layer is a bit weaker, which makes it more susceptible to irritants.

Current treatments include topical creams and corticosteroids, but these options don’t always provide lasting relief so there is a need for more effective treatment. Momentum is conducting a clinical research study exploring a potential new medicine designed to ease eczema symptoms such as itching and inflammation and potentially restore the skin barrier. 

What to expect

Participants will be randomly assigned to receive two subcutaneous (under the skin) injections of either the investigational product or a placebo (inactive substance). 

You’ll attend regular clinic visits for skin assessments, blood tests and study related health checks. Your safety and well-being will be closely monitored by a professional medical team throughout the study.

Why join this clinical research study?

  • Gain early access to the investigational product for eczema therapy at no cost
  • Contribute to research that could improve the lives of others living with eczema
  • Learn to better manage your condition
  • Receive study related health checks and advice from our professional medical team

Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.

This study is now closed

Please note that this study has now closed. However, we encourage you to pre-register your interest for future atopic dermatitis studies here. 

Eczema Studies
Therapeutic AreasClinical TrialsAboutContactCareersNews
ParticipantsSponsors

New Zealand locations

AucklandPukekohe AucklandNorth AucklandWest AucklandWaikatoTaurangaRotoruaPalmerston NorthHutt ValleyKapitiWellingtonNelsonChristchurchDunedin

Australian locations

Taringa BrisbaneSunshine MelbourneDarlinghurst SydneySt Leonards Sydney

2026 © Momentum Clinical Research

Privacy Policy